Evidence map›Paper›PMID 20558538›Full record

ArticleJournal of the American Society of Nephrology : JASN2010

Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

Mihailo Vujic, Christina M Heyer, Elisabet Ars, Katharina Hopp, Arseni Markoff, Charlotte Orndal, Bengt Rudenhed, Samih H Nasr, Vicente E Torres, Roser Torra and 2 more

Abstract readCase Reports
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Predictors of autosomal dominant polycystic kidney disease progression.Journal of the American Society of Nephrology : JASN · 2014
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  8. Polycystic Kidney Disease in Children: The Current Status and the Next Horizon.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. How Does ADPKD Severity Differ Between Family Members?Kidney international reports · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Mihailo VujicDepartments of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden.
Christina M Heyer
Elisabet Ars
Katharina Hopp
Arseni Markoff
Charlotte Orndal
Bengt Rudenhed
Samih H Nasr
Vicente E Torres
Roser Torra
Nadja Bogdanova
Peter C Harris
Hypertension Institute · USMRC Laboratory of Molecular Biology · GBGTx (United States) · USMayo Clinic · USSahlgrenska University Hospital · SE

Funding

ADPKD:Disease Spectrum &Genotype-Phenotype CorrelationsR01DK058816 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2001 to 2026
$11.3M
Transgenic and Knockout Models of ADPKDR01DK059597 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2002 to 2026
$9.5M
NIDDK NIH HHS DK58816NIDDK NIH HHS R01 DK058816NIDDK NIH HHS R01 DK059597
6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD), caused by mutation in PKD1 or PKD2, is usually an adult-onset disorder but can rarely manifest as a neonatal disease within a family characterized by otherwise typical ADPKD. Coinheritance of a hypomorphic PKD1 allele in trans with an inactivating PKD1 allele is one mechanism that can cause early onset ADPKD. Here, we describe two pedigrees without a history of cystic kidney disease that each contain two patients with onset of massive PKD in utero. The presentations were typical of autosomal recessive PKD (ARPKD) but they were not linked to the known ARPKD gene, PKHD1. Mutation analysis of the ADPKD genes provided strong evidence that both families inherited, in trans, two incompletely penetrant PKD1 alleles. These patients illustrate that PKD1 mutations can manifest as a phenocopy of ARPKD with respect to renal involvement and highlight the perils of linkage-based diagnostics in ARPKD without positive PKHD1 mutation data. Furthermore, the phenotypic overlap between ARPKD and these patients resulting from incomplete penetrant PKD1 alleles support a common pathogenesis for these diseases.

Indexed as

AllelesAmino Acid SequenceChildChild, PreschoolDiagnosis, DifferentialFemaleHumansInfantKidneyMagnetic Resonance ImagingMaleMolecular Sequence DataMutationPedigreePhenotypePolycystic Kidney, Autosomal RecessivePKHD1 protein, humanReceptors, Cell SurfaceTRPP Cation Channels

Identifiers

PMID20558538
PMCPMC3152226
OpenAlexW2146378413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.